Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells

Journal of General Virology

Volumn 88, Issue 1, 2007, Pages 148-156

  Palmer, Dupeh R ^a   Fernandez, Stefan ^a   Bisbing, John ^a   Peachman, Kristina K ^a   Rao, Mangala ^a   Barvir, Dave ^a   Gunther, Vicky ^a   Burgess, Timothy ^b   Kohno, Yukari ^c   Padmanabhan, R ^c   Sun, Wellington ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; LIVE VACCINE; YELLOW FEVER VACCINE;

ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; DENGUE VIRUS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; INTERNALIZATION; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; YELLOW FEVER FLAVIVIRUS;

ANIMALS; CERCOPITHECUS AETHIOPS; DENDRITIC CELLS; HUMANS; LYSOSOMES; VERO CELLS; VIRUS REPLICATION; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

DENGUE VIRUS; YELLOW FEVER VIRUS;

EID: 33846130030     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82272-0     Document Type: Article

References (39)

1. Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, 0., Corbi, A. L. & Delgado, R. (2002). C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76, 6841-6844.
2. Barba-Spaeth, G., Longman, R. S., Albert, M. L. & Rice, C. M. (2005). Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 202, 1179-1184.
3. Barros, V. E. D., Thomazini, J. A. & Figueiredo, L. T. M. (2004). Cytopathological changes induced by selected Brazilian flaviviruses in mouse macrophages. I Microsc 216, 5-14.
4. Brandler, S., Brown, N., Ermak, T. H., Mitchell, F., Parsons, M., Zhang, Z., Lang, J., Monath, T. P. & Guirakhoo, F. (2005). Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells. Am J Trop Med Hyg 72, 74-81.
5. Brandriss, M. W., Schlesinger, J. J. & Walsh, E. E. (1990). Immunogenicity of a purified fragment of 17D yellow fever envelope protein. J Infect Dis 161, 1134-1139.
6. Catteau, A., Kalinina, 0., Wagner, M.-C., Deubel, V., Courageot, M.-P. & Desprès, P. (2003). Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J Gen Virol 84, 2781-2793.
7. Chu, P. W. G. & Westaway, E. G. (1985). Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication. Virology 140, 68-79.
8. Co, M. D. T., Terajima, M., Cruz, J., Ennis, F. A. & Rothman, A. L. (2002). Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293, 151-163.
9. Desprèes, P., Flamand, M., Ceccaldi, P.-E. & Deubel, V. (1996). Human isolates of dengue type 1 virus induce apoptosis in mouse neuroblastoma cells. J Virol 70, 4090-4096.
10. 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A 85, 5259-5263.
11. Fox, J. P., Lennette, E. H., Manso, C. & Souza, J. R. (1942). Encephalitis in man following vaccination with 17 D yellow fever virus. Am J Hyg 36, 117-142.
12. Gardner, J. P., Durso, R. J., Arrigale, R. R., Donovan, G. P., Maddon, P. J., Dragic, T. & Olson, W. C. (2003). L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci U S A 100, 4498-4503.
13. Groot H. & Riberiro, R. B. (1962). Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine. Bull World Health Organ 27, 699-707.
14. Gruenberg, J. (2001). The enclocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol 2, 721-730.
15. Gubler, D. J. (2004). Cities spawn epidemic dengue viruses. Nat Med 10, 129-130.
16. Hahn, C. S., Hahn, Y. S., Rice, C. M., Lee, E., Dalgarno, L., Strauss, E. G. & Strauss, J. H. (1987). Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. I Mol Biol 198, 33-41.
17. Halary, F., Amara, A., Lortat-Jacob, H., Messerle, M., Delaunay, T., Houles, C., Fieschi, F., Arenzana-Seisdedos, F., Moreau, J. F. & Dechanet-Merville, J. (2002). Human cytornegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell transinfection. Immunity 17, 653-664.
18. Kroeger, A., Nathan, M., Hombach, J. & the World Health Organization TDR Reierence Group on Dengue (2004). Dengue. Nat Rev Microbiol 2, 360-361.
19. Kuno, G., Chang, G.-J. J., Tsuchiya, K. R., Karabatsos, N. & Cropp, C. B. (1998). Phylogeny of the genus Flavivirus. I Virol 72, 73-83.
20. Lakadamyali, M., Rust, M. J., Babcock, H. P. & Zhuang, X. (2003). Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100, 9280-9285.
21. Lambeth, C. R., White, L. J., Johnston, R. E. & de Silva, A. M. (2005). Flow cytometry-based assay for fitrating dengue virus. J Clin Microbial 43, 3267-3272.
22. Lee, E. & Lobigs, M. (2002). Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76, 4901-4911.
23. Liprandi, F. & Walder, R. (1983). Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937). Arch Viral 76, 51-61.
24. Marianneau, P., Desprès, P. & Deubel, V. (1 999a). Recent knowledge on the pathogenesis of yellow fever and questions for the future. Bull Soc Pathol Exot 92, 432-434 (in French).
25. Marianneau, P., Steffan, A.-M., Royer, C., Drouet, M.-T., Jaeck, D., Kim, A. & Deubel, V. (1999b). Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident. J Viral 73, 5201-5206.
26. Mathew, A., Kurane, I., Green, S., Vaughn, D. W., Kalayanarooj, S., Suntayakorn, S., Ennis, F. A. & Rothman, A. L. (1999). Impaired T cell proliferation in acute dengue infection. J Immunol 162, 5609-5615.
27. Navarro-Sanchez, E., Altmeyer, R., Amara, A., Schwartz, O., Fieschi, F., Virelizier, J.-L., Arenzana-Seisdeclos, F. & Desprès, P. (2003). Dendritic-cell- specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4, 723-728.
28. Palmer, D. R., Sun, P., Celluzzi, C., Bisbing, J., Pang, S., Sun, W., Marovich, M. A. & Burgess, T. (2005). Differential effects of dengue virus on infected and bystander dendritic cells. J Virol 79, 2432-2439.
29. Poland, J. D., Calisher, C. H., Monath, T. P., Downs, W. G. & Murphy, K. (1981). Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 59, 895-900.
30. Putnak, J. R. & Schlesinger, J. J. (1990). Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b. J Gen Virol 71, 1697-1702.
31. Quaresma, J. A. S., Barros, V. L. R. S., Fernandes, E. R., Pagliari, C., Takakura, C., da Costa Vasconcelos, P. F., de Andrade, H. F., Jr & Duarte, M. I. S. (2005). Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever. Acta Trop 94, 116-127.
32. Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R. & Pulendran, B. (2006). Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203, 413-424.
33. Rao, M., Rothwell, S. W., Wassef, N. M., Pagano, R. E. & Alving, C. R. (1997). Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages. Immunol Lett 59, 99-105.
34. Reinhardt, B., Jaspert, R., Niedrig, M., Kostner, C. & L'age-Stehr, J. (1998). Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol 56, 159-167.
35. Schlesinger, J. J., Brandriss, M. W., Cropp, C. B. & Monath, T. P. (1986). Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol 60, 1153-1155.
36. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S. & other authors (2003). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197, 823-829.
37. Theiler, M. & Smith, H. H. (1937). The use of yellow fever virus by in vitro cultivation for human immunization. J Exp Mcd 65, 787-800.
38. Uchil, P. D. & Satchidanandam, V. (2003). Characterization of RNA synthesis, replication mechanism, and in vitro RNA-dependent RNA polymerase activity of Japanese encephalitis virus. Virology 307, 358-371.
39. van Kooyk, Y. & Geijtenbeek, T. B. (2003). DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3, 697-709.